38 Building Research Capacity: The Impact of The Brain Tumour Charity’s Future Leaders Funding Programme

Clicks: 15
ID: 326715
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #248 of 287 articles by views in journal of neuro-oncology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 287 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Introduction Brain tumours remain one of the most challenging cancers, and progress is slowed by a shortage of researchers entering and remaining in the field. To build capacity, ensure research excellence and drive innovation, The Brain Tumour Charity established the Future Leaders Programme to identify talented early‑career researchers and support them to become leaders in brain tumour research. Methods The programme uses a staged funding model. Researchers undertake a three‑year Postdoctoral Fellowship, receiving £75,000 pa to build research skills and deliver high‑impact projects. This is followed by an invitation to apply for a four‑year Junior Fellowship, which provides £600,000 over four years. One Junior Fellow will then receive support totalling £1M in a five-year Senior Fellowship. Throughout this pathway, The Charity provides training, networking opportunities, and support. Results Assessing both the person and excellence of the science has proved extraordinarily successful, with many Future Leaders starting their own labs and driving clinical trials. The programme has supported a diverse portfolio of innovative projects. These include immune‑based approaches targeting IL‑10, blood‑based biomarkers to detect tumour recurrence, engineered “smart viruses”, and research defining the origins of meningioma. Our newest Junior Fellows, Dr. Ola Rominiyi and Dr. Christopher Mount, are advancing work on DNA repair mechanisms and CAR‑T cell therapy to address treatment resistance and accelerate immunotherapy development. Conclusions The Future Leaders programme provides sustained investment, structured career development, and an innovation‑focused environment. By empowering early‑career researchers to pursue ambitious projects, it accelerates discovery and contributes to improving outcomes for people affected by brain tumours. By 2030 almost 30 researchers will have passed through the scheme and form our wider Future Leaders Network, driving the research collaborations and discoveries of the future.
Reference Key
openalex_W7204452226 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lucy Grist, Simon Newman, Emma Thompson
Are you one of these authors? Claim your profile
Journal journal of neuro-oncology
Year 2026
DOI
10.1093/neuonc/noag172.077
URL
https://academic.oup.com/neuro-oncology/article-pdf/28/Supplement_1/noag172.077/70805939/noag172.077.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.